Results
Dishman Carbogen Amcis Q4 Revenue Up 19% YoY
Dishman Carbogen Amcis reported Q4 FY26 revenue of INR 851 crore, a 19% YoY growth, with strong performance in both CDMO and Vitamin D analogs segments.
The company announced Board approval for a long
